Solid Tumor Immunotherapy Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Verismo Therapeutics, Inc., a recent Penn spin-out behind a novel multichain KIR-CAR platform technology for CAR T-cells, today announced the.

University of pennsylvaniaUnited statesLauraa johnsonBryan kimSteven rosenbergAlyson kuritzMichael miloneSolid tumor immunotherapy labProfessor at duke universityPreclinical researchHlb ltdBrain tumor immunotherapy programPenn centerClinical developmentVerismo therapeutics incVerismo therapeutics